Lawton Alison Frances 4
4 · Kaleido Biosciences, Inc. · Filed Apr 17, 2020
Insider Transaction Report
Form 4
LAWTON ALISON FRANCIS
DirectorSee Remarks
Transactions
- Award
Stock Option (Right to Buy)
2020-04-15+118,500→ 118,500 totalExercise: $6.00Exp: 2030-04-14→ Common Stock (118,500 underlying)
Footnotes (1)
- [F1]25% of this option shall vest on April 15, 2021, with the remaining 75% vesting in 12 equal quarterly installments thereafter.